Aggressive and indolent non-Hodgkin's lymphoma: Response assessment by Integrated International Workshop Criteria-Reference-Cited by-同舟云学术

Aggressive and indolent non-Hodgkin's lymphoma: Response assessment by Integrated International Workshop Criteria

Published:2007-01 Issue:8 Volume:48 Page:1522-1530
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Brepoels Lieselot,Stroobants Sigrid,De Wever Walter,Spaepen Karoline,Vandenberghe Peter,Thomas Jose,Uyttebroeck Anne,Mortelmans Luc,De Wolf-Peeters Christiane,Verhoef Gregor

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.1080/10428190701474365

Reference19 articles.

1. Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas

2. How to interpret the radiological abnormalities that persist after treatment in non-Hodgkin’s lymphoma patients?

3. Prognostic Value of Positron Emission Tomography (PET) With Fluorine-18 Fluorodeoxyglucose ([18F]FDG) After First-Line Chemotherapy in Non-Hodgkin’s Lymphoma: Is [18F]FDG-PET a Valid Alternative to Conventional Diagnostic Methods?

4. Whole-Body Positron Emission Tomography Using18F-Fluorodeoxyglucose for Posttreatment Evaluation in Hodgkin’s Disease and Non-Hodgkin’s Lymphoma Has Higher Diagnostic and Prognostic Value Than Classical Computed Tomography Scan Imaging

5. Prognostic value of positron emission tomography in the evaluation of post-treatment residual mass in patients with Hodgkin's disease and non-Hodgkin's lymphoma

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2022 Chinese expert consensus and guidelines on clinical management of toxicity in anti-CD19 chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma;Cancer Biology & Medicine;2023-03-02

2. Diagnostic Applications of Nuclear Medicine: Lymphomas;Nuclear Oncology;2022

3. Diagnostic Applications of Nuclear Medicine: Lymphomas;Nuclear Oncology;2022

4. Prognostic impact of nutritional and inflammation-based risk scores in follicular lymphoma in the era of anti-CD20 targeted treatment strategies;Journal of Cancer Research and Clinical Oncology;2021-08-20

5. How we treat mature B-cell neoplasms (indolent B-cell lymphomas);Journal of Hematology & Oncology;2021-01-06